Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials

NCT00354003 is registered in ClinicalTrials.gov with Institute for Neurodegenerative Disorders as lead sponsor.

NCT NCT00354003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials
Lead sponsor
Institute for Neurodegenerative Disorders
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
August 31, 2008
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson, parkinsonian syndrome